Verition Fund Management LLC Orchard Therapeutics PLC Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.7 - $1.51 $6 - $13
-9 Reduced 0.02%
50,000 $36,000
Q4 2021

Feb 14, 2022
BUY
$1.16 - $2.23 $58,010 - $111,520
50,009 New
50,009 $66,000
Q1 2020

May 15, 2020
SELL
$5.65 - $15.71 $223,067 - $620,246
-39,481 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$10.15 - $15.58 $400,732 - $615,113
39,481 New
39,481 $543,000

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email